skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:033180/0221   Pages: 5
Recorded: 06/12/2014
Attorney Dkt #:P-140
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 4
1
Patent #:
Issue Dt:
04/12/2005
Application #:
10444847
Filing Dt:
05/23/2003
Publication #:
Pub Dt:
02/19/2004
Title:
CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS
2
Patent #:
Issue Dt:
02/07/2006
Application #:
10967578
Filing Dt:
10/18/2004
Publication #:
Pub Dt:
09/22/2005
Title:
CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS
3
Patent #:
Issue Dt:
07/29/2008
Application #:
11233220
Filing Dt:
09/22/2005
Publication #:
Pub Dt:
02/02/2006
Title:
CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS
4
Patent #:
Issue Dt:
12/27/2011
Application #:
12214554
Filing Dt:
06/19/2008
Publication #:
Pub Dt:
05/28/2009
Title:
CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS
Assignor
1
Exec Dt:
06/01/2014
Assignee
1
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA 94080
Correspondence name and address
JEFFREY A. HAGENAH
PATENT DEPARTMENT
THERAVANCE BIOPHARMA US, INC.
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA 94080

Search Results as of: 05/28/2024 03:07 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT